LIFEVANTAGE CORP Total Liabilities and Equity
LIFEVANTAGE CORP (LFVN) had Total Liabilities and Equity of $62.11 million as of 2026-06-30, per its 10-K filed 2026-08-27.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-27
- 2026-06-30: Liabilities and Equity $62.11M.
- 2026-03-31: Liabilities and Equity $62.13M.
- 2025-12-31: Liabilities and Equity $61.17M.
- 2025-09-30: Liabilities and Equity $61.58M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $62.11M 10-K · filed 2026-08-27 | |
| 2026-03-31 | $62.13M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $61.17M 10-Q · filed 2026-02-04 | |
| 2025-09-30 | $61.58M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $71.96M 10-K · filed 2026-08-27 | |
| 2025-03-31 | $77.24M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $68.53M 10-Q · filed 2025-02-05 | |
| 2024-09-30 | $61.46M 10-Q · filed 2024-10-29 | |
| 2024-06-30 | $60.30M 10-K · filed 2025-09-04 | |
| 2024-03-31 | $61.31M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $62.68M 10-Q · filed 2024-01-30 | |
| 2023-09-30 | $66.60M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $66.12M 10-K · filed 2024-08-28 | |
| 2023-03-31 | $67.08M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $67.83M 10-Q · filed 2023-02-02 | |
| 2022-09-30 | $67.60M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $70.71M 10-K · filed 2023-08-28 | |
| 2022-03-31 | $72.22M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $72.25M 10-Q · filed 2022-02-01 | |
| 2021-09-30 | $75.60M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $78.73M 10-K · filed 2022-08-23 | |
| 2021-03-31 | $75.12M 10-Q · filed 2021-04-29 | |
| 2020-12-31 | $74.43M 10-Q · filed 2021-02-02 | |
| 2020-09-30 | $70.21M 10-Q · filed 2020-11-03 | |
| 2020-06-30 | $58.88M 10-K · filed 2021-08-19 | |
| 2020-03-31 | $52.33M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $55.02M 10-Q · filed 2020-01-28 | |
| 2019-09-30 | $56.00M 10-Q · filed 2019-10-30 | |
| 2019-06-30 | $55.27M 10-K · filed 2020-08-18 | |
| 2019-03-31 | $54.10M 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $54.09M 10-Q · filed 2019-02-04 | |
| 2018-09-30 | $51.92M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $51.14M 10-K · filed 2019-08-14 | |
| 2018-03-31 | $50.93M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $45.66M 10-Q · filed 2018-02-07 | |
| 2017-09-30 | $44.79M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $45.25M 10-K · filed 2018-08-15 | |
| 2017-03-31 | $46.74M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $46.52M 10-Q · filed 2017-02-08 | |
| 2016-09-30 | $49.80M 10-Q · filed 2016-12-12 | |
| 2016-06-30 | $50.85M 10-K · filed 2017-09-07 | $50.26M 10-K · filed 2016-12-12 |
| 2016-03-31 | $44.12M 10-Q/A · filed 2016-07-19 | |
| 2015-12-31 | $44.93M 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $39.60M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $39.78M 10-K · filed 2016-12-12 | $40.88M 10-K · filed 2015-09-01 |
| 2015-03-31 | $46.93M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $51.05M 10-Q · filed 2015-02-04 | |
| 2014-09-30 | $56.68M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $54.00M 10-K · filed 2015-09-01 | |
| 2014-03-31 | $70.30M 10-Q · filed 2014-05-06 | |
| 2013-12-31 | $63.39M 10-Q · filed 2014-02-06 | |
| 2013-09-30 | $54.46M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $55.48M 10-K · filed 2014-09-10 | |
| 2013-03-31 | $54.48M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $54.83M 10-Q · filed 2013-02-07 | |
| 2012-09-30 | $50.02M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $44.53M 10-K · filed 2013-09-12 | $44.53M 10-K · filed 2012-09-10 |
| 2012-03-31 | $33.38M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $24.67M 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $17.11M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $12.50M 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |